Arcus Biosciences (RCUS) Income Annual - Discounting Cash Flows
Arcus Biosciences, Inc.
RCUS (NYSE)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing 2024-02-21 2023-02-28 2022-02-23 2021-02-25 2020-03-05 2019-03-05 2017-12-31 2016-12-31
Revenue
117 112 383 77.5 15.0 8.35 1.41 0.00
Cost of Revenue
340 14.0 7.06 159 78.5 49.6 2.61 1.31
Gross Profit
-223 98.0 376 -81.5 -63.5 -41.3 -1.20 -1.31
Operating Expenses
117 378 322 42.8 25.2 13.6 52.2 16.9
Research & Development
340 288 256 159 78.5 49.6 47.2 14.2
Selling, General and Administrative
117 104 72.3 42.4 25.2 13.6 7.64 3.94
Other Operating Expenses
-340 -14.0 -7.06 -159 -78.5 -49.6 -2.61 -1.31
Operating Income
-340 -280 54.2 -124 -88.7 -54.9 -53.4 -18.2
Net Non-Operating Interest
39.0 14.0 0.40 1.38 5.20 0.00 0.36 0.21
Interest Income
41.0 16.0 0.66 1.38 5.20 4.92 0.36 0.21
Interest Expense
2.00 2.00 0.26 0.00 0.00 4.92 0.00 0.00
Equity & Other Income/(Expense)
0.00 0.00 0.00 0.00 -1.20 5.26 0.00 0.00
Income Before Tax
-301 -266 54.6 -123 -84.7 -49.6 -53.1 -18.0
Income Tax Expense
6.00 1.00 1.82 -6.18 -8.78 5.26 0.00 0.00
Income Attributable to Non-Controlling Interest
0.00 0.00 -0.17 0.00 0.00 -5.26 0.00 0.00
Net Income
-307 -267 53.0 -117 -75.9 -49.6 -53.1 -18.0
Depreciation and Amortization
8.00 14.0 7.06 4.39 3.58 3.66 2.61 1.31
EBITDA
-332 -266 61.3 -120 -85.1 -51.2 -50.8 -16.9
Earnings Per Share (EPS)
-4.150 -3.710 0.760 -2.130 -1.730 -1.430 -1.250 -0.730
Diluted Earnings Per Share
-4.150 -3.710 0.710 -2.130 -1.730 -1.430 -1.250 -0.730
Weighted Average Shares Outstanding
74.0 72.0 69.3 54.8 43.8 34.6 42.6 24.6
Diluted Weighted Average Shares Outstanding
74.0 72.0 74.0 54.8 43.8 34.6 42.6 24.6
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us